Effect of Systemic Cooling in Vasospasms

This study has been completed.
Sponsor:
Information provided by:
University Hospital, Basel, Switzerland
ClinicalTrials.gov Identifier:
NCT00409123
First received: December 7, 2006
Last updated: September 25, 2008
Last verified: September 2008

December 7, 2006
September 25, 2008
September 2004
May 2006   (final data collection date for primary outcome measure)
  • LDF blood flow [ Time Frame: repeated after each challenge ] [ Designated as safety issue: No ]
  • LDF velocity [ Time Frame: repeated after each challenge ] [ Designated as safety issue: No ]
  • finger skin temperature [ Time Frame: repeated after each challenge ] [ Designated as safety issue: No ]
  • core body temperature [ Time Frame: repeated after each challenge ] [ Designated as safety issue: No ]
  • corneal temperature [ Time Frame: repeated after each challenge ] [ Designated as safety issue: No ]
LDF blood flow, LDF velocity, finger skin temperature, core body temperature, corneal temperature
Complete list of historical versions of study NCT00409123 on ClinicalTrials.gov Archive Site
  • subjective sleepiness [ Time Frame: repeated after each challenge ] [ Designated as safety issue: No ]
  • subjective ratings of thermal comfort [ Time Frame: repeated after each challenge ] [ Designated as safety issue: No ]
subjective sleepiness, subjective ratings of thermal comfort,
Not Provided
Not Provided
 
Effect of Systemic Cooling in Vasospasms
Effect of Systemic Cooling in Vasospasms (Kühleffekte Beim Vasospastischen Syndrom)

This study tests whether women with Vasospastic Syndrome (VS) react more intensive than controls with distal vasomotions and choroidal blood flow changes to internal cooling/warming and external cooling/warming.

Distal vasomotions and choroidal blood flow changes to internal cooling/warming and external cooling/warming was studied in VS and controls.Core cooling was induced by drinking of 250g ice/water mixture (4°C). Core warming was induced by drinking of 250g warm water (55°C). The study was controlled with respect to posture and room temperature.

Observational
Observational Model: Case-Only
Time Perspective: Prospective
Not Provided
Not Provided
Non-Probability Sample

vasospastic women

Vasospastic Syndrome
Not Provided
Not Provided
Not Provided

*   Includes publications given by the data provider as well as publications identified by ClinicalTrials.gov Identifier (NCT Number) in Medline.
 
Completed
28
June 2006
May 2006   (final data collection date for primary outcome measure)

Inclusion Criteria:

  • women
  • luteal phase or contraceptives
  • 19-35 years

Exclusion Criteria:

  • somatic diseases
  • psychiatric diseases
  • BMI > 25
  • BMI < 18
Female
19 Years to 35 Years
Yes
Contact information is only displayed when the study is recruiting subjects
Switzerland
 
NCT00409123
007-KRK-2004-001
No
Selim Orguel, MD, University Hospital, Basel, Switzerland
University Hospital, Basel, Switzerland
Not Provided
Study Director: Selim Orguel, MD Unversity Eye Clinic Basel
University Hospital, Basel, Switzerland
September 2008

ICMJE     Data element required by the International Committee of Medical Journal Editors and the World Health Organization ICTRP